Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

Older adults' immune systems naturally weaken with age, making them more susceptible to COVID-19, influenza (flu) and RSV. Here's what you need to know about these respiratory viruses and why ...

The NHS has begun inviting older people in Oxfordshire to receive their respiratory syncytial virus (RSV) vaccine.

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

A vaccination programme introduced to protect babies and older adults against a dangerous respiratory disease has cut ...

The respiratory syncytial virus (RSV) vaccine triggered strong immune responses among people aged 60 years and older during ...

The success of an ongoing pilot programme offering RSV vaccination to newborn infants provides hope in tackling the ...

Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...

In adults aged 50 years and older, coadministration of respiratory syncytial virus vaccine mRNA-1345 plus seasonal influenza or COVID-19 vaccines was safe and noninferior to individual vaccine ...

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

The new study, published in The Lancet Infectious Diseases, is the first to give evidence of the impact of the RSV vaccination program and underlines the importance of older adults coming forward ...

Live your life healthier and happier with our free weekly Living Well newsletter Older adults in England are being urged by health officials to get vaccinated against respiratory syncytial virus ...